09:13 AM EST, 11/21/2024 (MT Newswires) -- Health care stocks rose in pre-bell hours Thursday with the Health Care Select Sector SPDR Fund ( XLV ) 0.3% higher and the iShares Biotechnology ETF (IBB) up 0.5% recently.

Zymeworks ( ZYME ) and Jazz Pharmaceuticals ( JAZZ ) said they have received accelerated approval for Ziihera from the US Food and Drug Administration to treat adult patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer. Zymeworks ( ZYME ) shares were up nearly 7% and Jazz Pharmaceuticals ( JAZZ ) shares were over 2% higher premarket.

Nurix Therapeutics ( NRIX ) shares advanced by over 6% after the company said it received PRIME designation from the European Medicines Agency for NX-5948 to treat adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Zai Lab ( ZLAB ) and Pfizer ( PFE ) said they are collaborating on the commercialization of XACDURO in mainland China. Zai Lab ( ZLAB ) shares were down nearly 3% premarket.